Document is current
Any future updates will be listed below
-
Authors
Neumann, Alexander https://orcid.org/0000-0002-5651-3900
Schildhauer, P.
Weiler, S. M.
Schramm, P.
Schacht, H.
Royl, G.
Jensen-Kondering, U.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 5 November 2024
First Online: 23 November 2024
Declarations
:
: Our study has been reviewed by the appropriate ethics committee (University of Lübeck, file reference: 2023 − 662) and has therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1965 Declaration of Helsinki.
: All authors consent to the publication of this manuscript.
: HS: Lecture fee from Cercare Medical. GR: Compensation from Cardinal Health 200 LLC for consultant services; compensation from Novartis Pharma AG for other services; compensation from AstraZeneca for consultant services; travel support from Boehringer Ingelheim; compensation from Boehringer Ingelheim for consultant services; compensation from Ipsen Pharma SAS for consultant services; and compensation from Bristol-Myers Squibb for consultant services. UJK: Payment for attending a training course from Cerenovus. AN, PS, SMW, PS: None.
